Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas

Medical Oncology

Volumn 17, Issue 4, 2000, Pages 314-318

  Bairey, O ^a,b   Zimra, Y ^a,b   Kaganovsky, E ^a,b   Shaklai, M ^a,b   Okon, E ^a,b   Rabizadeh, E ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiogenesis; Chemoresistant; Chemosensitive; Microvessel count; Non Hodgkin's lymphoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; VINCRISTINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DENSITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0033767663     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02782197     Document Type: Article

References (29)

1. Clinical application of research on angiogenesis
2. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
3. What is the evidence that tumors are angiogenesis dependent?
4. Tumor vasculature a potential therapeutic target
5. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: More than a new prognostic tool
6. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
7. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
8. Tumor angiogenesis in advanced stage ovarian carcinoma
9. Angiogenesis in endometrial carcinoma
10. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
11. New prognostic factors in nasopharyngeal carcinoma
12. Prognostic significance of the microvascular count in colorectal cancer
13. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas
14. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma
15. Microvessel count predicts survival in uveal melanoma
16. Intratumor microvessel density as a prognostic factor in cancer
17. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphoma. An immunohistochemical and ultrastructural study
18. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
19. A revised European-American classification of lymphoid neoplasms: A proposal from the international Lymphoma Study Group
20. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
21. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
22. Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLAQ-4, LAM-1, and CD44
23. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
24. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma
25. Antitumor activity of thalidomide in refractory multiple myeloma
26. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
27. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
28. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
29. Expression of Bcl-2, Bcl-X, Bax and Bak proteins in short and long-lived patients with diffuse large B-cell lymphomas